Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12757721rdf:typepubmed:Citationlld:pubmed
pubmed-article:12757721lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C0033634lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C0043791lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C0559956lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C1707494lld:lifeskim
pubmed-article:12757721lifeskim:mentionsumls-concept:C0913252lld:lifeskim
pubmed-article:12757721pubmed:issue12lld:pubmed
pubmed-article:12757721pubmed:dateCreated2003-5-21lld:pubmed
pubmed-article:12757721pubmed:abstractTextIn order to determine the importance of the two ester pharmacophores in high affinity, conformationally constrained DAG-lactones (Lac-1-5) as PK-C ligands, we have independently replaced the sn-1 and sn-2 carbonyl esters in these compounds by ketone (2, 10, 11), amide (3, 25-28), and hydroxyl (12, 13) isosteres. Although the ketone analogue of the sn-1 ester (2) exhibited comparable activity to the parent Lac-1 when taking into account the difference in lipophilicities, the other isosteres were significantly poorer PK-C alpha ligands compared to the parent DAG-lactones. This study demonstrates that the ester functionality in DAG-lactone plays an important role in the ligand's capacity to form a strong hydrogen bond with Gly253 at the active site. The discrete K(i) analysis from the sn-1 and sn-2 isosteres further confirms that the DAG-lactones bind preferentially to the C1-domain in the sn-2 binding mode, as previously suggested.lld:pubmed
pubmed-article:12757721pubmed:languageenglld:pubmed
pubmed-article:12757721pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:citationSubsetIMlld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12757721pubmed:statusMEDLINElld:pubmed
pubmed-article:12757721pubmed:monthJunlld:pubmed
pubmed-article:12757721pubmed:issn0968-0896lld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:BlumbergPeter...lld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:MarquezVictor...lld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:LeeJeewooJlld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:LewinNancy...lld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:KimSu YeonSYlld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:KangJi-HyeJHlld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:ChungHye-EunH...lld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:KimYerimYlld:pubmed
pubmed-article:12757721pubmed:authorpubmed-author:PearceLarry...lld:pubmed
pubmed-article:12757721pubmed:issnTypePrintlld:pubmed
pubmed-article:12757721pubmed:day12lld:pubmed
pubmed-article:12757721pubmed:volume11lld:pubmed
pubmed-article:12757721pubmed:ownerNLMlld:pubmed
pubmed-article:12757721pubmed:authorsCompleteYlld:pubmed
pubmed-article:12757721pubmed:pagination2529-39lld:pubmed
pubmed-article:12757721pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:meshHeadingpubmed-meshheading:12757721...lld:pubmed
pubmed-article:12757721pubmed:year2003lld:pubmed
pubmed-article:12757721pubmed:articleTitleConformationally constrained analogues of diacylglycerol (DAG). Effect on protein kinase C (PK-C) binding by the isosteric replacement of sn-1 and sn-2 esters in DAG-lactones.lld:pubmed
pubmed-article:12757721pubmed:affiliationLaboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 151-742, South Korea.lld:pubmed
pubmed-article:12757721pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12757721pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12757721lld:pubmed